首页 | 本学科首页   官方微博 | 高级检索  
     


Transdermal Permeation and Skin Retention of Diclofenac and Etofenamate/Flufenamic Acid From Over-the-Counter Pain Relief Products
Authors:Monika Kopečná  Andrej Kováčik  Petr Novák  Mila Boncheva Bettex  Kateřina Vávrová
Affiliation:1. Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic;2. GSK Consumer Healthcare s.r.o, Hvězdova 1734/2c, 140 00 Praha 4, Czech Republic;3. GSK Consumer Healthcare S.A, Route de l''Etraz 2, Case Postale 1279, Nyon 1260, Switzerland
Abstract:Topical pain relief products differ in the type of drug, concentration, and formulation. All these factors influence the drug transit through the skin barrier, and its eventual retention in the skin as a reservoir for subsequent release. In addition, the drug potency can be different, which is important for the product efficacy. We studied here ex vivo human skin permeation and retention of five over-the-counter NSAID gels containing 2.32% diclofenac (DIC) and 5–10% etofenamate (ETF). The potency of the permeated/retained drug amounts were compared using a composite parameter, the Index of Relative Topical Anti-inflammatory Activity (IRTAA), which is calculated as the product of the skin permeation/retention and the drug relative potency. The IRTAAs of the DIC gel were 94–667-fold higher and 72–208-fold higher for transdermal delivery and skin retention, respectively, than IRTAAs of the ETF gels. These superior IRTAAs indicate that DIC delivered by this topical formulation would achieve a higher bioactivity and would form a potent drug reservoir relevant for its subsequent long-lasting release.
Keywords:Absorption  Drug delivery system(s)  Formulation  Percutaneous  Permeability  Skin  Transdermal
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号